April 21st 2024
Both the United Nations and World Health Organization (WHO) discussed the threat of H5N1, and its potential transmission to other mammals and humans.
Addressing Healthcare Inequities: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis
View More
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
6th Annual Advanced Practice Collaborative
View More
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care
View More
Identifying Actionable Biomarkers in NSCLC: Real World Case Discussions on Applications of Testing in the Treatment Planning Process
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Improving Outcomes Across Frontline and R/R SCLC Care in Community Treatment Settings
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
Charting the Path to Precision Diagnosis: Detection and Treatment Approaches for Oncogenic Mutations in NSCLC
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Cystic Fibrosis Patients Can Transmit Antibiotic-resistant Infections to Each Other
November 17th 2016In a new study, researchers from the United Kingdom have found that cystic fibrosis patients are more likely to pick up multi-drug resistant infections in hospitals than was previously believed.
Read More
Multidrug-resistant Tuberculosis More Widespread in Western Africa Than Previously Thought
November 13th 2016The scope of multidrug-resistant tuberculosis in West Africa, until recently, has not been well-understood, but a new study on eight countries in the region shows that the superbug is more common than previous estimates suggested.
Read More
How Clinical and Environmental Factors Impact Legionella Growth
November 12th 2016Laura Cooley, MD, MPH, medical epidemiologist, Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, explains why Legionella is such a challenging pathogen.
Watch
Why is Legionnaires' on the Rise in the US?
November 10th 2016Laura Cooley, MD, MPH, medical epidemiologist, Respiratory Diseases Branch, Division of Bacterial Disease, National Center for Immunization and Respiratory Disease, Centers for Disease Control and Prevention, explains the current Legionella situation.
Watch
Study Finds that Nearly One in Four Are Infected with Latent Tuberculosis
November 9th 2016A new study from United Kingdom researchers finds that nearly one-quarter of the global population is infected with latent tuberculosis (TB), a finding that exposes the challenges ahead for the World Health Organization’s End TB Strategy.
Read More
Influenza Antiviral Treatments: Prescribing Practices Across the US
November 8th 2016Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, explains her recent research on influenza antiviral treatment prescribing practices in 60 outpatient settings across the United States.
Watch
WHO Report Says We're Off Target on TB Epidemic
November 7th 2016The World Health Organization (WHO) has released their Global Tuberculosis Report for 2016, emphasizing that today’s global actions and investments are falling far short of what is needed to stop the worldwide tuberculosis (TB) epidemic.
Read More
Measuring the Impact of Comorbidities on 30-day Mortality in Older Adults with Pneumonia
November 4th 2016Jacob Morton, PharmD, MBA, BCPS, Antibiotic Stewardship Outcomes Post-Doctoral Research Fellow, Providence Veterans Affairs Medical Center, clinical pharmacy research specialist, Wesley Healthcare, discusses his research on 30-day mortality in adults with pneumococcal disease.
Watch
Effectiveness of Influenza Antiviral Treatment in Outpatient Settings
November 2nd 2016Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, explains how antiviral flu treatments may be affecting patients in the outpatient setting.
Watch
Populations at Risk for Flu-associated Complications and Recommended Treatments
October 29th 2016Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, discusses which outpatient populations are at highest risk of influenza-associated complications and the recommended treatments for these individuals.
Watch
New Tuberculosis Treatment Uses Old Antibiotics in Novel Ways
October 20th 2016While health officials continue to search for more novel tools to fight tuberculosis, a team of researchers has found that a class of antibiotics first introduced in the 1960s may offer an important weapon against the outbreaks of today.
Read More